000 | 01883 a2200493 4500 | ||
---|---|---|---|
005 | 20250516192426.0 | ||
264 | 0 | _c20140516 | |
008 | 201405s 0 0 eng d | ||
022 | _a1096-0333 | ||
024 | 7 |
_a10.1016/j.taap.2014.01.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCaruso, Joseph A | |
245 | 0 | 0 |
_aA systems toxicology approach identifies Lyn as a key signaling phosphoprotein modulated by mercury in a B lymphocyte cell model. _h[electronic resource] |
260 |
_bToxicology and applied pharmacology _cApr 2014 |
||
300 |
_a47-54 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAutoimmune Diseases _xchemically induced |
650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
650 | 0 | 4 |
_aBiomarkers _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 |
_aMercury _xtoxicity |
650 | 0 | 4 |
_aMercury Poisoning _xenzymology |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aOsmolar Concentration |
650 | 0 | 4 |
_aPeptide Fragments _xagonists |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
650 | 0 | 4 |
_aProtein Tyrosine Phosphatases _xpharmacology |
650 | 0 | 4 |
_aReceptors, Antigen, B-Cell _xagonists |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTandem Mass Spectrometry |
650 | 0 | 4 |
_aTyrosine _xmetabolism |
650 | 0 | 4 |
_aVanadates _xpharmacology |
650 | 0 | 4 |
_asrc-Family Kinases _xantagonists & inhibitors |
700 | 1 | _aStemmer, Paul M | |
700 | 1 | _aDombkowski, Alan | |
700 | 1 | _aCaruthers, Nicholas J | |
700 | 1 | _aGill, Randall | |
700 | 1 | _aRosenspire, Allen J | |
773 | 0 |
_tToxicology and applied pharmacology _gvol. 276 _gno. 1 _gp. 47-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.taap.2014.01.002 _zAvailable from publisher's website |
999 |
_c23463708 _d23463708 |